LORENCE KIM

Profile

First Name

: LORENCE

Middle Name

:

Last Name

: KIM

Related Companies
Titles
Company Name
Related People
DIRECTOR
SERES HEALTH, INC.
NOUBAR AFEYAN, JOHN AUNINS, GREG BEHAR, DAVID BERRY, WERNER CAUTREELS, DAVID COOK, PETER BARTON HUTT, RICHARD KENDER, ROGER POMERANTZ, ROGER J. POMERANTZ, ERIC D. SHAFF
EXECUTIVE OFFICER
MODERNA LLC
NOUBAR AFEYAN, LEE BABISS, STEPHANE BANCEL, ROBERT CARPENTER, PETER HUTT, JAMES KASINGER, ROBERT LANGER, THEO MELAS-KYRIAZI, JOHN MENDLEIN, HENRI TERMEER
EXECUTIVE OFFICER
MODERNA THERAPEUTICS, INC.
NOUBAR AFEYAN, LEE BABISS, STEPHANE BANCEL, STEPHEN HOGE, PETER HUTT, JAMES R. KASINGER, ROBERT LANGER, JOHN MENDLEIN, ELIZABETH NABEL, HENRI TERMEER
DIRECTOR
ABATA THERAPEUTICS, INC.
ELLEN CAHIR-MCFARLAND, ABBIE CELNIKER, SHELLEY CHU, LEONARD DRAGONE, MITCH FINER, DAVID KAUFMAN, SANDY LAZZARI, NAGESH MAHANTHAPPA, VALERIE ODEGARD, SAMANTHA SINGER, STEPHEN SOFEN, JOHN TRZUPEK
DIRECTOR
ADARX PHARMACEUTICALS, INC.
EREZ CHIMOVITS, SIMEON GEORGE, CARL GORDON, SHEILA GUJRATHI, JUDITH LI, ZHEN LI, HONGBO LU, RICKY SUN, YUAN SUN, YUAN (ELIZA) SUN, CHEN YU, XIONG ZHANG, RUI ZHU
EXECUTIVE OFFICER
ASCENTA CAPITAL SPV I, L.P.
N/A ASCENTA CAPITAL FUND I GP, L.L.C., EVAN RACHLIN
EXECUTIVE OFFICER
ASCENTA CAPITAL PROJECT TURING SPV, L.P.
N/A ASCENTA CAPITAL FUND I GP, L.L.C., EVAN RACHLIN
DIRECTOR
ODYSSEY THERAPEUTICS, INC.
CHARLES BAUM, CHARLES M. BAUM, CHUCK BAUM, M. CHARLES BAUM, JILL CARROLL, SHELLEY CHU, GARY D GLICK, GARY D. GLICK, CARL GORDON, JASON HAAS, PAULINA HILL, JEFFREY LEIDEN, NAN LI, CAROLYN NG, VALERIE ODEGARD, KSENIJA PAVLETIC, IAN SMITH, LAN F. SMITH, NIA TATSIS, TIMOTHY WALBERT
EXECUTIVE OFFICER
ASCENTA CAPITAL PROJECT ARGOS SPV, L.P.
N/A ASCENTA CAPITAL FUND I GP, L.L.C., EVAN RACHLIN
EXECUTIVE OFFICER
ASCENTA CAPITAL FUND I, L.P.
N/A ASCENTA CAPITAL FUND I GP, L.L.C., EVAN RACHLIN
EXECUTIVE OFFICER
ASCENTA CAPITAL PROJECT IKIGAI SPV, L.P.
N/A ASCENTA CAPITAL FUND I GP, L.L.C., EVAN RACHLIN
EXECUTIVE OFFICER
ASCENTA CAPITAL PROJECT HENRI SPV, L.P.
N/A ASCENTA CAPITAL FUND I GP, L.L.C., EVAN RACHLIN
DIRECTOR
TRIANA BIOMEDICINES, INC.
NATHANIEL BROOKS HORWITZ, SHELLEY CHU, MILIND DESHPANDE, DAVID GRAYZEL, ANDREW HEDIN, ANDREW LEVIN, CHRISTOPHER O-DONNEL, CHRISTOPHER O-DONNELL, JIGAR RAYTHATHA, SIMON READ, JOSHUA RESNICK, PATRICK TROJER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-11-26 
2025-02-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2023-05-25 
2024-09-18
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2024-09-04 
2024-08-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
2024-07-10
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2024-06-26 
2024-02-09
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2023-05-25 
2023-12-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-12-14 
2023-12-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
2023-10-24
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2023-10-12 
2023-09-27
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2023-09-15 
2023-08-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-02 
2023-01-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-26 
2023-01-24
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2023-01-16 
2022-06-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-04 
2021-06-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-04 
2016-08-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-10 
2015-01-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-19 
2015-01-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-12-19 
2014-12-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-24